BRIANNA BRANCATO: Open Payments
NPI 1093326571 · MILLVILLE, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,236 in 52 payments from 14 companies in 2025. Trend: 2023 $851 · 2024 $969 · 2025 $1,236
Food & beverage: $1,236
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $277 |
| Madrigal Pharmaceuticals | 7 | $233 |
| Janssen Scientific Affairs, LLC | 2 | $188 |
| QOL Medical, LLC | 9 | $167 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $73 |
| Ardelyx, Inc. | 3 | $62 |
| GENZYME CORPORATION | 2 | $60 |
| Janssen Biotech, Inc. | 4 | $58 |
| Ferring Pharmaceuticals Inc. | 1 | $25 |
| PFIZER INC. | 1 | $21 |
Products named: TREMFYA, REZDIFFRA, Sucraid, LINZESS, DUPIXENT, XIFAXAN, IBSRELA, SKYRIZI.
Industry payments across DE — which companies pay providers there.
